期刊文献+

MDM2和p53蛋白在膀胱癌中过度表达的意义 被引量:1

CLINICAL SIGNIFICANCE OF OVER EXPRESSION OF MDM2 AND p53 PROTEIN IN BLADDER CANCER
暂未订购
导出
摘要 目的 观察膀胱癌中 MDM2和 p5 3蛋白的表达状况及意义。方法 用免疫组化检测 70例原发性膀胱移行细胞癌 (TCC)中 MDM2和 p5 3蛋白的过度表达情况。结果  MDM2核免疫阳性 44 .2 9% (31/ 70 ) ,32例 (45 .71% )p5 3核染色阳性 ,两者共同阳性 9例。 MDM2表达是膀胱癌的早期表现 ,p5 3蛋白与 MDM2相反 ,两者呈负相关 (r=-0 .5 34 6 ,0 .0 5 >P>0 .0 1)。结论  MDM2和 p5 Objective To observe and study the expression of MDM2 and p53 proteins and its significance in bladder cancers. Methods Using immuno histo chemical method to investigate the expression of MDM2 and p53 proteins in 70 cases of primary transitional cell carcinoma (TCC) of urinary bladder. Results MDM2 showed a nucleo immuno positive rate of 44 29 % (31/70), 32 cases showed a nuclear stain positive rate of 45 71 % of p53, and 9 cases showed both positive. Expression of MDM2 was an early manifestation of bladder cancers, however, p53 protein is just on the contrary and showed a negative correlation ( r= -0 5346, 0 05> P >0 01). Conclusion MDM2 and p53 proteins are an early and a late gene events in the occurrence and progress of bladder cancers.
出处 《肿瘤》 CAS CSCD 北大核心 2000年第2期133-134,共2页 Tumor
关键词 膀胱肿瘤 基因产物 MDM2 基因表达 Bladder neoplasma Gene products, MDM2 Gene products,p53
  • 相关文献

参考文献7

  • 1[1]Lane DP. p53,guardian of the genome[J]. Nature, 1992, 358:15
  • 2[2]Picksley SM, Vojtesek B, Sparks A, et al. Immunochemical analysis of the interaction of p53 with MDM2; -fine mapping of the MDM2 binding site on p53 using synthetic peptides[J]. Oncogene, 1994, 9:2523
  • 3[3]Fakharzadch SS, Tursko SP, George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line[J]. EMBO J, 1991, 10:1565
  • 4[4]Haines DS, Landers JE, Engle LJ, et al. Physical and functional interaction between wild-type p53 and MDM2 proteins[J]. Mol Cell Biol, 1994, 14:1171
  • 5[5]Oliner JD, Kinzler KW, Meltzer PS, et al. Amplification of a gene encoding a p53-associated protein in human sarcomas[J]. Nature, 1992, 358:80
  • 6[6]Barbareachi M, Girlando S, Fellin G, et al. Expression of MDMw and p53 protein in transitional cell carcinoma[J]. Urol, Res, 1995, 22:349
  • 7[7]Olum AF. Allelic loss of chromosome 17p distinguishes high grade transitional cell carcinomas of the bladder[J]. Cancer Res, 1990, 50:708

同被引文献8

  • 1白福鼎 史时芳.膀胱癌组织及尿脱落细胞CD44v6表达的研究[J].中华泌尿外科杂志,1999,20(2):101-101.
  • 2Fradet Y. Molecular and immunologic approaches in the management of bladder cancer[J]. Urol Clin North Am, 1991,18(3):515-524.
  • 3Sheinfeld J, Reuter VE, Melamed MR, et al. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation[J]. J Urol, 1990,143(2):285-288.
  • 4Tanaka K, Takashi M, Miyake K, et al. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer[J]. Urol Int, 1994, 52(3):140-144.
  • 5Longin A, Fontaniere B, Berger-Dutrieux N, et al. A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology[J]. Cancer, 1990,65(6):1 412-1 417.
  • 6吴忠,张元芳,刘定干,李载平,贺斌.从膀胱癌尿脱落细胞中提取RNA进行RT-PCR的研究[J].中华实验外科杂志,1997,14(5):287-288. 被引量:5
  • 7王翔,张元芳,叶烈,夫丁强,瞿连喜.膀胱癌尿脱落细胞端粒酶活性检测及其临床意义[J].中华泌尿外科杂志,1999,20(5):267-269. 被引量:15
  • 8缪思满,罗义麒,王向宇,黄纲雄,曹林升,林曦.p16和cyclin D_1在膀胱癌中的表达及其相关性研究[J].中华泌尿外科杂志,1999,20(7):419-421. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部